115 related articles for article (PubMed ID: 24722136)
1. X-linked adrenoleukodystrophy: are signs of hypogonadism always due to testicular failure?
Karapanou O; Vlassopoulou B; Tzanela M; Papadopoulos D; Angelidakis P; Michelakakis H; Ioannidis G; Mihalatos M; Kamakari S; Tsagarakis S
Hormones (Athens); 2014; 13(1):146-52. PubMed ID: 24722136
[TBL] [Abstract][Full Text] [Related]
2. Reproductive function in men affected by X-linked adrenoleukodystrophy/adrenomyeloneuropathy.
Stradomska TJ; Kubalska J; Janas R; Tylki-Szymanska A
Eur J Endocrinol; 2012 Feb; 166(2):291-4. PubMed ID: 22048970
[TBL] [Abstract][Full Text] [Related]
3. An unusual presentation of X-linked adrenoleukodystrophy.
Suryawanshi A; Middleton T; Ganda K
Endocrinol Diabetes Metab Case Rep; 2015; 2015():150098. PubMed ID: 26609365
[TBL] [Abstract][Full Text] [Related]
4. Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study.
Assies J; Gooren LJ; Van Geel B; Barth PG
Int J Androl; 1997 Oct; 20(5):315-21. PubMed ID: 16130276
[TBL] [Abstract][Full Text] [Related]
5. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
[TBL] [Abstract][Full Text] [Related]
6. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice.
Forss-Petter S; Werner H; Berger J; Lassmann H; Molzer B; Schwab MH; Bernheimer H; Zimmermann F; Nave KA
J Neurosci Res; 1997 Dec; 50(5):829-43. PubMed ID: 9418970
[TBL] [Abstract][Full Text] [Related]
7. Endocrine Dysfunction in X-Linked Adrenoleukodystrophy.
Burtman E; Regelmann MO
Endocrinol Metab Clin North Am; 2016 Jun; 45(2):295-309. PubMed ID: 27241966
[TBL] [Abstract][Full Text] [Related]
8. [X-linked adrenoleukodystrophy].
Aubourg P
Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
[TBL] [Abstract][Full Text] [Related]
9. Rapid decline of fertility in a case of adrenoleukodystrophy.
Aversa A; Palleschi S; Cruccu G; Silvestroni L; Isidori A; Fabbri A
Hum Reprod; 1998 Sep; 13(9):2474-9. PubMed ID: 9806270
[TBL] [Abstract][Full Text] [Related]
10. [Screening for carrier and prenatal diagnosis of X-linked adrenoleukodystrophy].
Wang AH; Bao XH; Xiong H; Pan H; Wu Y; Zhang YH; Shi CY; Qin J; Wu XR
Zhonghua Er Ke Za Zhi; 2005 May; 43(5):345-9. PubMed ID: 15924749
[TBL] [Abstract][Full Text] [Related]
11. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.
Engelen M; Barbier M; Dijkstra IM; Schür R; de Bie RM; Verhamme C; Dijkgraaf MG; Aubourg PA; Wanders RJ; van Geel BM; de Visser M; Poll-The BT; Kemp S
Brain; 2014 Mar; 137(Pt 3):693-706. PubMed ID: 24480483
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of patients with X-linked adrenoleukodystrophy: A retrospective cohort study.
Tran C; Patel J; Stacy H; Mamak EG; Faghfoury H; Raiman J; Clarke JTR; Blaser S; Mercimek-Mahmutoglu S
Eur J Paediatr Neurol; 2017 Jul; 21(4):600-609. PubMed ID: 28274546
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy.
Asheuer M; Bieche I; Laurendeau I; Moser A; Hainque B; Vidaud M; Aubourg P
Hum Mol Genet; 2005 May; 14(10):1293-303. PubMed ID: 15800013
[TBL] [Abstract][Full Text] [Related]
14. [X-linked adrenoleukodystrophy--2 case reports].
Dumić M; Ille J; Plavsić V; Filipović-Grcić B; Vrljicak K; Barisić N; Roscher A
Lijec Vjesn; 1998; 120(1-2):19-23. PubMed ID: 9650481
[TBL] [Abstract][Full Text] [Related]
15. Adult onset cerebral form of X-linked adrenoleukodystrophy with dementia of frontal lobe type with new L160P mutation in ABCD1 gene.
Sutovský S; Petrovic R; Chandoga J; Turcáni P
J Neurol Sci; 2007 Dec; 263(1-2):149-53. PubMed ID: 17662307
[TBL] [Abstract][Full Text] [Related]
16. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.
Laureti S; Casucci G; Santeusanio F; Angeletti G; Aubourg P; Brunetti P
J Clin Endocrinol Metab; 1996 Feb; 81(2):470-4. PubMed ID: 8636252
[TBL] [Abstract][Full Text] [Related]
17. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
[TBL] [Abstract][Full Text] [Related]
18. Cerebral childhood and adolescent X-linked adrenoleukodystrophy. Clinical presentation, neurophysiological, neuroimaging and biochemical investigations.
Zgorzalewicz-Stachowiak M; Stradomska TJ; Bartkowiak Z; Galas-Zgorzalewicz B
Folia Neuropathol; 2006; 44(4):319-26. PubMed ID: 17183459
[TBL] [Abstract][Full Text] [Related]
19. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset cerebello-brainstem dominant form of X-linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review.
Ogaki K; Koga S; Aoki N; Lin W; Suzuki K; Ross OA; Dickson DW
Neuropathology; 2016 Feb; 36(1):64-76. PubMed ID: 26227820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
